Australia markets open in 54 minutes

Abbott Laboratories (ABT)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
105.27-0.63 (-0.59%)
At close: 04:00PM EDT
105.75 +0.48 (+0.46%)
After hours: 07:05PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
6,896,000
9,882,000
9,799,000
6,838,000
Other short-term investments
383,000
288,000
450,000
310,000
Total cash
7,279,000
10,170,000
10,249,000
7,148,000
Net receivables
6,565,000
6,218,000
6,487,000
6,414,000
Inventory
6,570,000
6,173,000
5,157,000
5,012,000
Total current assets
22,670,000
25,224,000
24,239,000
20,441,000
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
21,933,000
20,212,000
19,364,000
18,793,000
Accumulated depreciation
-11,779,000
-11,050,000
-10,405,000
-9,764,000
Net property, plant and equipment
10,154,000
9,162,000
8,959,000
9,029,000
Equity and other investments
799,000
766,000
816,000
821,000
Goodwill
23,679,000
22,799,000
23,231,000
23,744,000
Intangible assets
8,815,000
10,454,000
12,739,000
14,784,000
Other long-term assets
7,097,000
6,033,000
5,212,000
3,729,000
Total non-current assets
50,544,000
49,214,000
50,957,000
52,107,000
Total assets
73,214,000
74,438,000
75,196,000
72,548,000
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
1,080,000
2,251,000
754,000
220,000
Accounts payable
4,295,000
4,607,000
4,408,000
3,946,000
Taxes payable
492,000
343,000
306,000
362,000
Accrued liabilities
6,369,000
6,763,000
6,442,000
6,265,000
Total current liabilities
13,841,000
15,489,000
13,105,000
11,907,000
Non-current liabilities
Long-term debt
13,599,000
14,522,000
17,296,000
18,527,000
Deferred tax liabilities
568,000
991,000
1,392,000
1,406,000
Other long-term liabilities
3,466,000
3,804,000
3,685,000
3,684,000
Total non-current liabilities
20,546,000
22,044,000
26,067,000
27,638,000
Total liabilities
34,387,000
37,533,000
39,172,000
39,545,000
Stockholders' equity
Common stock
24,869,000
24,709,000
24,470,000
24,145,000
Retained earnings
37,554,000
35,257,000
31,528,000
27,627,000
Accumulated other comprehensive income
-7,839,000
-8,051,000
-8,374,000
-8,946,000
Total stockholders' equity
38,603,000
36,686,000
35,802,000
32,784,000
Total liabilities and stockholders' equity
73,214,000
74,438,000
75,196,000
72,548,000